Fidelity Management & Research Co.. recently announced the acquisition of new stake in Amyris Inc. (NASDAQ:AMRS). The institutional investor has increased its shareholding in the Basic Materials company by 9.41% to 14.12 million shares with purchase of 1.21 million shares. This fresh investment now brings its stake to 6.90% valued currently at $60.45 million. In addition, Farallon Capital Management LLC raised its holdings by 6.08 million to 13.09 million shares. And BlackRock Fund Advisors has lifted its position by 47.58% or 2.0 million shares – to 6.21 million shares.
With over 2.2 million Amyris Inc. (AMRS) shares trading Monday and a closing price of $3.28 on the day, the dollar volume was approximately $7.2 million. The shares have shown a negative weekly performance of -4.93% and its price on 08/31/20 lost nearly -2.96%. Currently, there are 184.83M common shares owned by the public and among those 116.10M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 2 analysts who have offered their price forecasts for AMRS have a consensus price objective of $10.00. The analysts have set the share’s price value over the next 12 months at a high of $11.00 and a low of $9.00 should the stock experience a downside. Incidentally, analysts’ outlook for the Amyris Inc. stock is 1.50 for the next 12 months. But an upside of 70.18% will see the stock hit the forecast high price target while mean target price for the stock is $10.00.
Insiders at the company have transacted a total of 50 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 37 of these insider trades were purchases, accounting for 40,412,972 shares. Insider sales of the common stock occurred on 13 occasions, with total insider shares sold totaling 314,242 shares.
The top 3 mutual fund holders in Amyris Inc. are Fidelity Balanced Fund, Fidelity Strategic Advisers US To, and Victory RS Small Cap Growth Fund. Fidelity Balanced Fund owns 9.9 million shares of the company’s stock, all valued at over $42.35 million. The company bought an additional 0.1 million shares recently to bring their total holdings to about 4.84% of the shares outstanding. Fidelity Strategic Advisers US To bought 38810.0 shares to see its total holdings expand to 2.41 million shares valued at over $10.34 million and representing 1.18% of the shares outstanding. Victory RS Small Cap Growth Fund bought 2.25 million shares to bring its total holdings to over 2.25 million shares at a value of $9.62 million. Victory RS Small Cap Growth Fund now owns shares totaling to 1.10% of the shares outstanding.
Shares of Amyris Inc. (NASDAQ: AMRS) opened at $3.39, up $0.01 from a prior closing price of $3.38. However, the script later closed the day at $3.28, down -2.96%. The company’s stock has a 5-day price change of -4.93% and -32.51% over the past three months. AMRS shares are trading 6.15% year to date (YTD), with the 12-month market performance down to -13.23% lower. It has a 12-month low price of $1.40 and touched a high of $6.07 over the same period. Currently, 2.2 million shares have been traded, compared to an average intraday trading volume of 2.71 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -11.57%, -19.66%, and -3.20% respectively.
Institutional ownership of Amyris Inc. (NASDAQ: AMRS) shares accounts for 42.20% of the company’s 184.83M shares outstanding. Mutual fund holders own 20.14%, while other institutional holders and individual stakeholders account for 50.54% and 15.75% respectively.
It has a market capitalization of $633.76M and a beta (3y monthly) value of 0.46. The earnings-per-share (ttm) stands at -$2.20. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.37% over the week and 7.94% over the month.
Analysts forecast that Amyris Inc. (AMRS) will achieve an EPS of -$0.17 for the current quarter, -$0.05 for the next quarter and -$0.32 for 2021. The lowest estimate earnings-per-share for the quarter is -$0.2 while analysts give the company a high EPS estimate of -$0.14. Comparatively, EPS for the current quarter was -$0.51 a year ago. Earnings per share for the fiscal year are expected to increase by 27.80%, and 74.00% over the next financial year. EPS should grow at an annualized rate of 30.00% over the next five years, compared to -51.90% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 2 brokerage firm advisors rate Amyris Inc. (AMRS) as a “Strong Buy” at a consensus score of 1.50. Specifically, 2 Wall Street analysts polled rate the stock as a buy, while 0 of the 2 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the AMRS, a number of firms have released research notes about the stock. Oppenheimer stated their Outperform rating for the stock in a research note on December 12, 2019, with the firm’s price target at $8. B. Riley FBR coverage for the Amyris Inc. (AMRS) stock in a research note released on November 14, 2018 offered a Buy rating with a price target of $8. B. Riley FBR Inc. was of a view on January 25, 2018 that the stock is Buy, while Stifel gave the stock Hold rating on May 28, 2014, issuing a price target of. Deutsche Bank on their part issued Hold rating on February 10, 2012.